Viewing Study NCT05648669


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-01-04 @ 2:34 PM
Study NCT ID: NCT05648669
Status: UNKNOWN
Last Update Posted: 2022-12-13
First Post: 2022-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module